Behavioral interventions in treating anticipatory nausea and vomiting

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 1, 2007, Pages 44-50

  Figueroa Moseley, Colmar ^a   Jean Pierre, Pascal ^a   Roscoe, Joseph A ^a   Ryan, Julie L ^a   Kohli, Sadhna ^a   Palesh, Oxana G ^a   Ryan, Elizabeth P ^a   Carroll, Jennifer ^a   Morrow, Gary R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Anticipatory nausea and vomiting; Cancer; Clinical management

Indexed keywords

ALPRAZOLAM; CANNABINOID DERIVATIVE; CISPLATIN; CLEMASTINE; DEXAMETHASONE; GABAPENTIN; LORAZEPAM; METOCLOPRAMIDE; OLANZAPINE; SEROTONIN 3 ANTAGONIST;

ACUPRESSURE; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANTICIPATORY ANXIETY; ANTICIPATORY NAUSEA AND VOMITING; BEHAVIOR THERAPY; CANCER; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COGNITIVE THERAPY; CONDITIONING; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MEGADOSE; GUIDED IMAGERY; HUMAN; HYPNOSIS; LOW DRUG DOSE; MEDICAL EDUCATION; MEDICAL PRACTICE; MUSCLE RELAXATION; MUSCLE TRAINING; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECREATION; REVIEW; VOMITING;

EID: 33846837435     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2007.0006     Document Type: Review

References (57)

1. Osoba D, Zee B, Warr D, et al. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 1997;5:307-313.
2. Cooper S, Georgiou V. The impact of cytotoxic chemotherapy - perspectives from patients, specialists and nurses. Eur J Cancer 1992;28A[suppl 1]:S36-38.
3. Love RR, Leventhal H, Easterling DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer 1989;63:604-612.
4. Stewart DJ. Cancer therapy, vomiting, and antiemetics. Can J Physiol Pharmacol 1990;68:304-313.
5. Burish TG Carey MP. Conditioned aversive responses in cancer chemotherapy patients: theoretical and developmental analysis. J Consult Clin Psychol 1986;54:593-600.
6. Parker LA, Kwiatkowska M, Mechoulam R. Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting. Physiol Behav 2006;87:66-71.
7. Morrow GR, Roscoe JA, Hynes HE, et al. Progress in reducing anticipatory nausea and vomiting: a study of community practice. Support Care Cancer 1998;6:46-50.
8. Razavi D, Delvaux N, Farvacques C, et al. Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 1993;11:1384-1390.
9. Carey MP, Burish TG. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull 1988;104:307-325.
10. Montgomery GH, Bovbjerg DH. The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer. Physiol Behav 1997;61:737-741.
11. Morrow GR, Lindke J, Black PM. Predicting development of anticipatory nausea in cancer patients: prospective examination of eight clinical characteristics. J Pain Symptom Manage 1991;6:215-223.
12. Roscoe JA, Morrow GR, Hickok JT, Stern RM. Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage 2000;20:113-121.
13. Andrykowski MA, Redd WH, Hatfield AK. Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol 1985;53:447-454.
14. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer 1995;76:343-357.
15. Kirsch I, Lynn SJ, Vigorito M, Miller RR. The role of cognition in classical and operant conditioning. J Clin Psychol 2004;60:369-392.
16. Hickok JT, Roscoe JA, Morrow GR. The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage 2001;22:843-850.
17. Roscoe JA, Morrow GR, Hickok JT, et al. Biobehavioral factors in chemotherapy induced nausea and vomiting. J Natl Compr Canc Netw 2004;2:501-508.
18. Walton SM. Advances in use of the 5-HT3 receptor antagonists. Expert Opin Pharmacother 2000;1:207-223.
19. Sharma R, Tobin P, Clarke SJ, et al. Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol 2005;6:93-102.
20. Malik IA, Khan WA, Qazilbash M, et al. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 1995;18:170-175.
21. Collins KB, Thomas DJ. Acupuncture and acupressure for the management of chemotherapy-induced nausea and vomiting. J Am Acad Nurse Pract 2004;16:76-80.
22. Reindl TK, Geilen W, Hartmann R, et al. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study. Support Care Cancer 2006;14:172-176.
23. Yugin L. Treating patients with nervous vomiting in the dental office by point-stimulating therapy. Spec Care Dentist 1989;9:27-28.
24. Morrow GR, Morrell C. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 1982;307:1476-1480.
25. Morrow GR, Asbury R, Hammon S, et al. Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol 1992;11:250-256.
26. Yoo HJ, Ahn SH, Kim SB, et al. Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life. Support Care Cancer 2005;13:826-833.
27. Burish TG, Lyles JN. Effectiveness of relaxation training in reducing the aversiveness of chemotherapy in the treatment of cancer. J Behav Ther Exp Psychiatry 1979;10:357-361.
28. Burish TG, Carey MP, Krozely MG, Greco FA. Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. J Consult Clin Psychol 1987;55:42-48.
29. Lyles JN, Burish TG, Krozely MG, Oldham RK. Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy. J Consult Clin Psychol 1982;50:509-524.
30. Morrow GR, Dobkin PL. Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, etiology, and behavioral interventions. Clin Psychol Rev 1988;8:517-556.
31. Spiegel D, Spiegel H. Hypnosis in psychosomatic medicine. Psychosomatics 1980;21:35-41.
32. Morrow GR. The assessment of nausea and vomiting: past problems, current issues, and suggestions for future research. Cancer 1984;53:2267-2278.
33. Burish TG, Jenkins RA. Effectiveness of biofeedback and relaxation training in reducing the side effects of cancer chemotherapy. Health Psychol 1992;11:17-23.
34. Morrow GR. Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: a component comparison with relaxation only, counseling, and no treatment. Cognitv Ther Res 1986;10:421-446.
35. Burish TG, Vasterling JJ, Carey MP, et al. Posttreatment use of relaxation training by cancer patients. Hosp J 1988;4:1-8.
36. Lerman C, Rimer B, Blumberg B, et al. Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses. Cancer Nurs 1990;13:308-315.
37. Elam CL, Andrykowski MA. Admission interview ratings: relationship to applicant academic and demographic variables and interviewer characteristics. Acad Med 1991;66[suppl 9]:S13-15.
38. Hailey BJ, White JG. Systematic desensitization for anticipatory nausea associated with chemotherapy. Psychosomatics 1983;24:287-291.
39. Hoffman ML. Hypnotic desensitization for the management of anticipatory emesis in chemotherapy. Am J Clin Hypn 1982;25:173-176.
40. LaBaw W, Holton C, Tewell K, Eccles D. The use of self-hypnosis by children with cancer. Am J Clin Hypn 1975;17:233-238.
41. Cotanch P, Hockenberry M, Herman S. Self-hypnosis as antiemetic therapy in children receiving chemotherapy. Oncol Nurs Forum 1985;12:41-46.
42. Kolko DJ, Rickard-Figueroa JL. Effects of video games on the adverse corollaries of chemotherapy in pediatric oncology patients: a single-case analysis. J Consult Clin Psychol 1985;53:223-228.
43. Redd WH, Andrykowski MA. Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy. J Consult Clin Psychol 1982;50:1018-1029.
44. Marchioro G, Azzarello G, Viviani F, et al. Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology 2000;59:100-104.
45. Redd WH, Andresen GV, Minagawa RY. Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. J Consult Clin Psychol 1982;50:14-19.
46. Jacknow DS, Tschann JM, Link MP, Boyce WT. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. J Dev Behav Pediatr 1994;15:258-264.
47. Zeltzer LK, Dolgin MJ, LeBaron S, LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991;88:34-42.
48. Walker LG, Dawson AA, Pollet SM, et al. Hypnotherapy for chemotherapy side effects. British Journal of Clinical and Experimental Hypnosis 1988;5:79-82.
49. Olness K. Imagery (self-hypnosis) as adjunct therapy in childhood cancer: clinical experience with 25 patients. Am J Pediatr Hematol Oncol 1981;3:313-321.
50. Zeltzer L, LeBaron S, Zeltzer PM. The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol 1984;2:683-690.
51. Zeltzer L, Kellerman J, Ellenberg L, Dash J. Hypnosis for reduction of vomiting associated with chemotherapy and disease in adolescents with cancer. J Adolesc Health Care 1983;4:77-84.
52. Redd WH, Jacobsen PB, Die-Trill M, et al. Cognitive/attentional distraction in the control of conditioned nausea in pediatric cancer patients receiving chemotherapy. J Consult Clin Psychol 1987;55:391-395.
53. Vasterling J, Jenkins RA, Tope DM, Burish TG. Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med 1993;16:65-80.
54. Andrews PLR, Sanger GJ, eds. Emesis in Anti-Cancer Therapy Mechanisms and Treatment. London: Chapman and Hall Medical, 1993.
55. Fallowfield LJ. Behavioural interventions and psychological aspects of care during chemotherapy. Eur J Cancer 1992;28A[suppl 1]:S39-41.
56. Morrow GR. Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol 1984;2:1170-1176.
57. Morrow GR. Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin 1989;39:89-104.